commensal bacterial strain formulation BMC128

An oral formulation composed of four unique and live commensal bacterial strains that are natural inhabitants of the human intestinal tract, with potential immunostimulating and antineoplastic activities. Upon administration of the commensal bacterial strain formulation BMC128, the bacterial strains may promote intra-tumoral lymphocytic infiltration and increase the population of natural killer (NK) cells, and cytotoxic CD4+ and CD8+ T cells. This may enhance anti-tumor immune response and may eradicate tumor cells.